Galderma Group AG: EQT Completes Share Sale for CHF 1.86 Billion
Deal News | Jun 03, 2025 | EQT
EQT, a global investment organization, has announced the successful completion of an accelerated bookbuild for the sale of 19,031,811 shares in Galderma Group AG, generating gross proceeds of approximately CHF 1.86 billion. Of this, EQT received around CHF 494 million. The transaction was finalized on June 2, 2025. The sale was managed by global coordinators and bookrunners from Goldman Sachs, Jefferies, Morgan Stanley, RBC, and UBS. Founded in 1981, Galderma Group AG is a leader in dermatology, spanning around 90 countries and offering a diverse range of products in injectable aesthetics, dermatological skincare, and therapeutic dermatology. EQT manages a significant portfolio of assets globally and highlights its focus on sustainable growth and operational excellence.
Sectors
- Private Equity
- Healthcare
- Financial Services
Geography
- Switzerland – Galderma Group AG is listed on the SIX Swiss Exchange and the transaction pertains to this location.
- United States – The global financial institutions involved are based in the U.S. and there's a notice about U.S. securities regulations.
Industry
- Private Equity – EQT is a private equity firm and a significant player in the investment management industry focused on strategic asset transactions.
- Healthcare – Galderma Group AG is a prominent player in the dermatology sector, offering a wide range of products and services within the healthcare industry.
- Financial Services – The involvement of financial institutions like Goldman Sachs, Morgan Stanley, and others classifies part of the article in the financial services sector.
Financials
- CHF 1.86 billion – Total gross proceeds from the sale of shares in Galderma Group AG.
- CHF 494 million – Proceeds received by EQT from the transaction.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EQT | Seller | Company | A global investment organization managing a wide array of assets globally, involved in completing the sale. |
| Galderma Group AG | Target Company | Company | A pure-play leader in the dermatology category with a global presence. |
| Goldman Sachs | Financial Advisor | Company | Acted as one of the joint global coordinators and joint bookrunners for the transaction. |
| Jefferies | Financial Advisor | Company | Served as a joint global coordinator and joint bookrunner for the placement. |
| Morgan Stanley | Financial Advisor | Company | Participated as a joint global coordinator and joint bookrunner. |
| RBC | Financial Advisor | Company | Engaged as a joint global coordinator and joint bookrunner. |
| UBS | Financial Advisor | Company | Joint global coordinator and bookrunner in the transaction. |